Skip to main content
. 2010 Jan;31(1):40–48. doi: 10.3174/ajnr.A1787

Table 1:

Patient demographic and clinical information

Subject Age (yr), Sex Primary Tumor (grade) RT Type, Dose, Timing (completed prior to imaging) Steroids at Imaging
A 31, M AA (III) 60-Gy 3D conformal (9 mo) Yes
25-Gy salvage IMRT (2 mo)
B 58, M GBM (IV) 54-Gy 3D conformal (22 mo) Yes
12-Gy gamma knife (5 mo)
C 36, M GBM (IV) 60-Gy IMRT (3 mo) None
D 56, M GBM (IV) 60-Gy IMRT (23 mo) Yes
30-Gy IMRT (10 mo)
E 45, F GBM (IV) 60-Gy 3D conformal (26 mo) None
Fa Excluded due to motion
G 50, M GBM (IV) 37.5-Gy whole brain RT (8 mo) Yes
30-Gy IMRT (5 mo)
Hb 38, M Ana. GG (III) 59.4-Gy IMRT (28.5 mo) Yes
12-Gy gamma knife (15.5 mo)
I 59, M GBM (IV) 59.4-Gy IMRT (13 mo) None
Ja Excluded due to motion
K 62, M GBM (IV) 54-Gy 3D conformal (12 mo) None
Lb 38, M Ana. GG (III) 54-Gy IMRT (24 months) None
12-Gy gamma knife (11 mo)
M 43, M GBM (IV) 60-Gy 3D conformal (8 mo) Yes
10-Gy gamma knife (7 mo)

Note:—RT indicates radiation therapy; AA, anaplastic astrocytoma; GBM, glioblastoma multiforme; Ana. GG, anaplastic ganglioglioma; IMRT, intensity modulated radiation therapy.

a

Excluded from analysis due to motion during scanning.

b

A single patient who underwent 2 separate surgeries 4.5 months apart.